These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35088959)

  • 1. [Should Tetanus Vaccine Booster be Given Earlier in Individuals Living with HIV?].
    Nazlı A; Kenanoğlu B; Işıkgöz Taşbakan M; Pullukçu H; Zeytinoğlu A; Gökengin D
    Mikrobiyol Bul; 2022 Jan; 56(1):49-58. PubMed ID: 35088959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of tetanus toxoid antibody and booster vaccination efficacy in Japanese travelers.
    Mizuno Y; Yamamoto A; Komiya T; Takeshita N; Takahashi M
    J Infect Chemother; 2014 Jan; 20(1):35-7. PubMed ID: 24462422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune status and booster effects of low doses of tetanus toxoid in Swedish medical personnel.
    Björkholm B; Wahl M; Granström M; Hagberg L
    Scand J Infect Dis; 1994; 26(4):471-5. PubMed ID: 7984981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decline of tetanus antitoxin level with age in taiwan.
    Wu CJ; Ko HC; Lee HC; Tsai WC; Li MG; Pao YZ; Lee NY; Chang CM; Shih HI; Ko WC
    J Formos Med Assoc; 2009 May; 108(5):395-401. PubMed ID: 19443293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetanus vaccination, antibody persistence and decennial booster: a serosurvey of university students and at-risk workers.
    Borella-Venturini M; Frasson C; Paluan F; DE Nuzzo D; DI Masi G; Giraldo M; Chiara F; Trevisan A
    Epidemiol Infect; 2017 Jul; 145(9):1757-1762. PubMed ID: 28294099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serological study carried out in Cambodia during a tetanus vaccination in adults].
    Schlumberger M; Yvonnet B; Que HV; Chhem DB; Saliou P; Le Tu TC; Glaziou P
    Bull Soc Pathol Exot; 2008 Feb; 101(1):36-42. PubMed ID: 18432006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diphtheria, tetanus and pertussis antibodies in 10-year-old children before and after a booster dose of three toxoids: implications for the timing of a booster dose.
    Trollfors B; Knutsson N; Taranger J; Mark A; Bergfors E; Sundh V; Lagergård T
    Eur J Pediatr; 2006 Jan; 165(1):14-8. PubMed ID: 16249929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Durability of tetanus seroprotection in people living with HIV.
    Dauby N; Gobert C; Benslimane A; Nagant C; Necsoi C; van den Wijngaert S; Corazza F; Delforge M; De Wit S
    AIDS; 2022 Jul; 36(8):1135-1139. PubMed ID: 35212671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetanus immunity in individuals aged 50 years or older in Kashan, Iran.
    Razzaghi R; Khalifesoltani A; Heravi MM; Akbari H
    Acta Med Iran; 2011; 49(6):379-82. PubMed ID: 21874642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroepidemiology of tetanus in Hangzhou from 2009 to 2018.
    Xu Y; Liu Y; Du J; Zheng W; Liu S; Zhang X; Zhang X; Wang J; Che X; Gu W; Jiang W
    Hum Vaccin Immunother; 2020 Nov; 16(11):2670-2676. PubMed ID: 32460603
    [No Abstract]   [Full Text] [Related]  

  • 11. Subnormal and waning immunity to tetanus toxoid in previously vaccinated HIV-infected children and response to booster doses of the vaccine.
    Choudhury SA; Matin F
    Int J Infect Dis; 2013 Dec; 17(12):e1249-51. PubMed ID: 24139228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes.
    Kroon FP; van Dissel JT; de Jong JC; van Furth R
    AIDS; 1994 Apr; 8(4):469-76. PubMed ID: 7912086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular and humoral immune responses to a tetanus toxoid booster in perinatally HIV-1-infected children and adolescents receiving highly active antiretroviral therapy (HAART).
    Ching N; Deville JG; Nielsen KA; Ank B; Wei LS; Sim MS; Wolinsky SM; Bryson YJ
    Eur J Pediatr; 2007 Jan; 166(1):51-6. PubMed ID: 16868780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decennial administration in young adults of a reduced-antigen content diphtheria, tetanus, acellular pertussis vaccine containing two different concentrations of aluminium.
    Vandermeulen C; Theeten H; Rathi N; Kuriyakose S; Han HH; Sokal E; Hoppenbrouwers K; Van Damme P
    Vaccine; 2015 Jun; 33(26):3026-34. PubMed ID: 25613716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretravel consultation: rapid dipstick test as a decision guidance for the application of tetanus booster vaccinations.
    Paulke-Korinek M; Rendi-Wagner P; Kundi M; Tomann B; Wiedermann U; Kollaritsch H
    J Travel Med; 2008; 15(6):437-41. PubMed ID: 19090799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and safety of a second booster dose of an acellular pertussis vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after a first booster in adolescence: An open, phase III, non-randomized, multi-center study.
    Kovac M; Kostanyan L; Mesaros N; Kuriyakose S; Varman M
    Hum Vaccin Immunother; 2018; 14(8):1977-1986. PubMed ID: 29630439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing immune competence in pigs by immunization with tetanus toxoid.
    Gimsa U; Tuchscherer A; Gimsa J; Tuchscherer M
    Animal; 2018 Jan; 12(1):116-121. PubMed ID: 28554336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria-tetanus-toxoid and acellular pertussis vaccine for primary and for booster immunizations.
    Schmitt HJ; Zepp F; Müschenborn S; Sümenicht G; Schuind A; Beutel K; Knuf M; Bock HL; Bogaerts H; Clemens R
    Eur J Pediatr; 1998 Mar; 157(3):208-14. PubMed ID: 9537487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the baseline tetanus antibody level and its persistence in a military unit.
    Tong L; Jia Q; Li B; Li Z; Qi J; Guo Z; Liu Y
    Vaccine; 2021 Jul; 39(31):4328-4334. PubMed ID: 34147291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of IgG antibodies against tetanus toxoid among different age groups in Poland.
    Śmietańska K; Rastawicki W
    Ann Agric Environ Med; 2024 Sep; 31(3):329-333. PubMed ID: 39344719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.